Abstract
THE mechanisms by which mitogenic G-protein-coupled receptors activate the MAP kinase signalling pathway are poorly understood. Candidate protein tyrosine kinases that link G-protein-coupled receptors with MAP kinase include Src family kinases1, the epidermal growth factor receptor2, Lyn and Syk3. Here we show that lysophosphatidic acid (LPA) and bradykinin induce tyrosine phosphorylation of Pyk2 and complex formation between Pyk2 and activated Src. Moreover, tyrosine phosphorylation of Pyk2 leads to binding of the SH2 domain of Src to tyrosine 402 of Pyk2 and activation of Src. Transient overexpres-sion of a dominant interfering mutant of Pyk2 or the protein tyrosine kinase Csk reduces LPA- or bradykinin-induced activation of MAP kinase. LPA- or bradykinin-induced MAP kinase activation was also inhibited by overexpression of dominant interfering mutants of Grb2 and Sos. We propose that Pyk2 acts with Src to link Gi- and Gq-coupled receptors with Grb2 and Sos to activate the MAP kinase signalling pathway in PC12 cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sadoshima, J. & Izumo, S. EMBO J. 15, 775–787 (1996).
Daub, H., Weiss, F. U., Wallasch, C. & Ullrich, A. Nature 379, 557–564 (1996).
Wan, Y., Kurosaki, T. & Huang, X. Y. Nature 380, 541–544 (1996).
van Biesen, T. et al. Nature 376, 781–784 (1995).
Lev, S. et al. Nature 376, 737–745 (1995).
Chen, Y.-H. et al. J. Biol. Chem. 269, 27372–27377 (1994).
Jalink, K., Eichholtz, T., Postma, F. R., vanCorven, E. J. & Moolenaar, W. H. Cell Growth Differ. 4, 247–255 (1993).
Simonson, M. S., Wang, Y. & Herman, W. H. J. Biol. Chem. 271, 77–82 (1996).
Liu, X. et al. Oncogene 8, 1119–1126 (1993).
Courtneidge, S. A. et al. EMBO J. 12, 943–950 (1993).
Songyang, Z. et al. Cell 72, 76–778 (1993).
Nada, S., Okada, M., MacAuley, A., Cooper, J. A. & Nakagawa, H. Nature 351, 69–72 (1991).
Tokiwa, G., Dikic, I., Lev, S. & Schlessinger, J. Science 273, 792–794 (1996).
Xie, Y., Pendergast, A. M. & Hung, M. C. J. Biol. Chem. 270, 30717–30724 (1995).
Gishizky, M. L., Cortez, D. & Pendergast, A. M. Proc. Natl Acad. Sci. USA 92, 10889–10893 (1995).
Chen, Y. et al. EMBO J. 15, 1037–1044 (1996).
Dikic, I., Schlessinger, J. & Lax, I. Curr. Biol. 4, 702–708 (1994).
Dikic, I. et al. J. Biol. Chem. 270, 15125–15129 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dikic, I., Tokiwa, G., Lev, S. et al. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383, 547–550 (1996). https://doi.org/10.1038/383547a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/383547a0
This article is cited by
-
Protein tyrosine phosphatases in skeletal development and diseases
Bone Research (2022)
-
Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance
British Journal of Cancer (2022)
-
Co-receptor signaling in the pathogenesis of neuroHIV
Retrovirology (2021)
-
The non-receptor tyrosine kinase Pyk2 modulates acute locomotor effects of cocaine in D1 receptor-expressing neurons of the nucleus accumbens
Scientific Reports (2020)
-
PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
Cell Death & Disease (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
